Sort
64,565 grants matching “drug discovery”
DNA Topoisomerases as Target of Action of Anticancer Drugs
$712,998Yves Pommier · Basic Sciences · Z01 · FY2007 · CA
Neonatal Opioid Exposure and Withdrawal: Molecular and Behavioral Consequences
$712,968Julie A Blendy · University Of Pennsylvania · R01 · FY2021 · DA
Injectable naltrexone 2-month depot formulations
$712,935Kinam Park · Purdue University · UG3 · FY2019 · DA
Design and development of HDAC11-specific chemical inhibitors for disease treatments
$712,892Edward Seto · George Washington University · R01 · FY2021 · AI
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
$712,883Vilmundur Gudnason · Icelandic Heart Association · R01 · FY2021 · AG
SAN ANTONIO CANCER INSTITUTE
$712,822Cancer Therapy And Research Center · P30 · FY2003 · CA
NCI Pediatric In Vivo Testing Program: Neuroblastoma
$712,800Yael P Mosse · Children'S Hosp Of Philadelphia · U01 · FY2023 · CA
NCI Pediatric In Vivo Testing Program: Neuroblastoma
$712,800Yael P Mosse · Children'S Hosp Of Philadelphia · U01 · FY2021 · CA
NCI Pediatric In Vivo Testing Program: Neuroblastoma
$712,799Yael P Mosse · Children'S Hosp Of Philadelphia · U01 · FY2024 · CA
NCI Pediatric In Vivo Testing Program: Neuroblastoma
$712,799Yael P Mosse · Children'S Hosp Of Philadelphia · U01 · FY2025 · CA
Small Molecule Discovery for Particulate Guanylyl Cyclase Receptor B Enhancers
$712,741Sasantha Jeson Sangaralingham · Mayo Clinic Rochester · R01 · FY2018 · AG
Small molecule enhancers of tumor immunity targeting the LPA5 GPCR
$712,726Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2024 · CA
Protein Tyrosine Dephosphorylation & Signal Transduction
$712,640Nicholas K Tonks · Cold Spring Harbor Laboratory · R01 · FY2010 · CA
Discovery of long-acting, chemoprotective antimalarial compounds
$712,608Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2021 · AI
Genomics
$712,546Daniel Rene Salomon · Scripps Research Institute, The · U19 · FY2012 · AI
Discovery and CRISPR validation of genetic factors associated with antipsychotic-induced weight gain and cardiometabolic risk
$712,527Ginger E Nicol · Washington University · R01 · FY2023 · MH
Identification and Development of Anti-Flavivirus Lead Drug Candidates
$712,509Jay A Nelson · University Of Alabama At Birmingham · U19 · FY2014 · AI
Optimization and preclinical development of FAAH inhibitors for smoking cessation
$712,368Daniele Piomelli · University Of California-Irvine · DP1 · FY2013 · DA
Epigenetic Modifications of BDNF and trkB Genes Underlie Pain Plasticity
$712,271Susan G Dorsey · University Of Maryland Baltimore · R01 · FY2010 · NR
Re-engineering gp120 to include glycan-dependent epitopes
$712,069Phillip Berman · University Of California Santa Cruz · R01 · FY2017 · AI
Development of Novel Antiviral Agents VS West Nile Virus
$712,013Washington University · U01 · FY2002 · AI
Molecular pathways affected by drugs that disrupt Na+ and lipid homeostasis in malaria parasites
$711,975Akhil B Vaidya · Drexel University · R01 · FY2023 · AI
An Imaging Repository for the Cerebrovascular Disease Knowledge Portal (iCDKP)
$711,910Jonathan Rosand · Broad Institute, Inc. · U24 · FY2024 · NS
High-Resolution ROMA Analysis of Genome Copy Number Variation in the HapMap
$711,784Jonathan Sebat · Cold Spring Harbor Laboratory · P41 · FY2008 · HG
Center for Interventional Oncology
$711,768Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2018 · CA